Overview

Duration of Analgesia With Dexmedetomidine and Ropivacaine in Brachial Plexus Block

Status:
Withdrawn
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, double blind study of adding dexmedetomidine to ropivacaine for Brachial plexus block and assessing the analgesia with VAS pain scales(0-10), Satisfaction scale by VAS scale(0-10) and time to first analgesic consumption. This study mainly aims to investigate whether addition of dexmedetomidine helps in increasing the duration of analgesia.
Phase:
Phase 4
Details
Lead Sponsor:
University of Florida
Treatments:
Dexmedetomidine
Ropivacaine